Cambridge, MA, United States of America

Lauren M Drouin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Voyager Therapeutics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lauren M Drouin. Retrieved from https://idiyas.com/inventor/lauren-m-drouin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Lauren M Drouin in AADC Viral Vectors

Introduction

Lauren M Drouin is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of analytical tools for measuring the potency of AADC viral vectors. Her work is crucial for advancing gene therapy techniques.

Latest Patents

Lauren holds a patent titled "Methods for measuring the potency of AADC viral vectors." This patent presents improved analytical tools, systems, and methods related to AADC viral vectors. It includes AADC potency assays for measuring and analyzing AADC expression potency, specifically focusing on enzymatic activity related to AADC vectors such as adeno-associated virus (AAV) AADC vectors. She has 1 patent to her name.

Career Highlights

Lauren is currently employed at Voyager Therapeutics, Inc., where she continues to innovate in the field of gene therapy. Her expertise in AADC viral vectors has positioned her as a key figure in her organization.

Collaborations

Some of her notable coworkers include Eric D Horowitz and Carlo Ciatto, who contribute to the collaborative environment at Voyager Therapeutics, Inc.

Conclusion

Lauren M Drouin's work in the field of AADC viral vectors exemplifies the impact of innovative thinking in biotechnology. Her contributions are paving the way for advancements in gene therapy and related fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…